{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:42:06Z","timestamp":1740109326777,"version":"3.37.3"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00059-018-4710-6","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T08:48:13Z","timestamp":1525855693000},"page":"415-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Device therapy in heart failure with reduced ejection fraction\u2014cardiac resynchronization therapy and more","Devicetherapie bei Herzinsuffizienz mit eingeschr\u00e4nkter Ejektionsfraktion \u2013 kardiale Resynchronisationstherapie und mehr"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2996-6338","authenticated-orcid":false,"given":"D.","family":"Duncker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Veltmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,9]]},"reference":[{"key":"4710_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.4070\/kcj.2017.0030","volume":"47","author":"D Berliner","year":"2017","unstructured":"Berliner D, Bauersachs J (2017) Current drug therapy in chronic heart failure: the new guidelines of the European Society of Cardiology (ESC). Korean Circ\u00a0J 47:543\u2013554. \n                    https:\/\/doi.org\/10.4070\/kcj.2017.0030","journal-title":"Korean Circ J"},{"issue":"27","key":"4710_CR2","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD et\u00a0al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart\u00a0J 37(27):2129\u20132200. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"key":"4710_CR3","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJV McMurray","year":"2014","unstructured":"McMurray JJV, Packer M, Desai AS et al (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N\u00a0Engl J Med 371:993\u20131004. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1409077","journal-title":"N Engl J Med"},{"key":"4710_CR4","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A et al (2015) 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC)endorsed by: association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart\u00a0J 36:2793\u20132867. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehv316","journal-title":"Eur Heart J"},{"key":"4710_CR5","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.hrthm.2012.07.009","volume":"9","author":"DO Martin","year":"2012","unstructured":"Martin DO, Lemke B, Birnie D et al (2012) Investigation of a\u00a0novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm 9:1807\u20131814. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2012.07.009","journal-title":"Heart Rhythm"},{"key":"4710_CR6","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1056\/NEJM200103223441202","volume":"344","author":"S Cazeau","year":"2001","unstructured":"Cazeau S, Leclercq C, Lavergne T et\u00a0al (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N\u00a0Engl J Med 344:873\u2013880. \n                    https:\/\/doi.org\/10.1056\/NEJM200103223441202","journal-title":"N Engl J Med"},{"key":"4710_CR7","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/S0735-1097(02)01895-8","volume":"39","author":"A Auricchio","year":"2002","unstructured":"Auricchio A, Stellbrink C, Sack S et al (2002) Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 39:2026\u20132033","journal-title":"J. Am. Coll. Cardiol."},{"key":"4710_CR8","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa013168","volume":"346","author":"WT Abraham","year":"2002","unstructured":"Abraham WT, Fisher WG, Smith AL et\u00a0al (2002) Cardiac resynchronization in chronic heart failure. N\u00a0Engl J Med 346:1845\u20131853. \n                    https:\/\/doi.org\/10.1056\/NEJMoa013168","journal-title":"N Engl J Med"},{"key":"4710_CR9","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","volume":"361","author":"AJ Moss","year":"2009","unstructured":"Moss AJ, Hall WJ, Cannom DS et al (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N\u00a0Engl J Med 361:1329\u20131338. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0906431","journal-title":"N Engl J Med"},{"key":"4710_CR10","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","volume":"363","author":"ASL Tang","year":"2010","unstructured":"Tang ASL, Wells GA, Talajic M et al (2010) Cardiac-resynchronization therapy for mild-to-moderate heart failure. N\u00a0Engl J Med 363:2385\u20132395. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1009540","journal-title":"N Engl J Med"},{"key":"4710_CR11","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMoa050496","volume":"352","author":"JGF Cleland","year":"2005","unstructured":"Cleland JGF, Daubert J\u2011C, Erdmann E et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N\u00a0Engl J Med 352:1539\u20131549. \n                    https:\/\/doi.org\/10.1056\/NEJMoa050496","journal-title":"N Engl J Med"},{"key":"4710_CR12","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1056\/NEJMoa032423","volume":"350","author":"MR Bristow","year":"2004","unstructured":"Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N\u00a0Engl J Med 350:2140\u20132150. \n                    https:\/\/doi.org\/10.1056\/NEJMoa032423","journal-title":"N Engl J Med"},{"key":"4710_CR13","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.amjcard.2010.11.010","volume":"107","author":"DG Strauss","year":"2011","unstructured":"Strauss DG, Selvester RH, Wagner GS (2011) Defining left bundle branch block in the era of cardiac resynchronization therapy. Am J Cardiol 107:927\u2013934. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2010.11.010","journal-title":"Am J Cardiol"},{"key":"4710_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jelectrocard.2012.12.003","volume":"46","author":"AR Bryant","year":"2013","unstructured":"Bryant AR, Wilton SB, Lai MP, Exner DV (2013) Association between QRS duration and outcome with cardiac resynchronization therapy: a\u00a0systematic review and meta-analysis. J\u00a0Electrocardiol 46:147\u2013155. \n                    https:\/\/doi.org\/10.1016\/j.jelectrocard.2012.12.003","journal-title":"J Electrocardiol"},{"key":"4710_CR15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/eurjhf\/hfp074","volume":"11","author":"R Gervais","year":"2009","unstructured":"Gervais R, Leclercq C, Shankar A et al (2009) Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a\u00a0sub-analysis of the CARE-HF trial. Eur J Heart Fail 11:699\u2013705. \n                    https:\/\/doi.org\/10.1093\/eurjhf\/hfp074","journal-title":"Eur J Heart Fail"},{"key":"4710_CR16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1161\/CIRCULATIONAHA.110.960898","volume":"123","author":"W Zareba","year":"2011","unstructured":"Zareba W, Klein H, Cygankiewicz I et al (2011) Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 123:1061\u20131072. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.960898","journal-title":"Circulation"},{"key":"4710_CR17","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/europace\/eus396","volume":"15","author":"M D\u00f6ring","year":"2013","unstructured":"D\u00f6ring M, Braunschweig F, Eitel C et al (2013) Individually tailored left ventricular lead placement: lessons from multimodality integration between three-dimensional echocardiography and coronary sinus angiogram. Europace 15:718\u2013727. \n                    https:\/\/doi.org\/10.1093\/europace\/eus396","journal-title":"Europace"},{"key":"4710_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12471-015-0777-3","volume":"24","author":"AMW Stipdonk van","year":"2016","unstructured":"van Stipdonk AMW, Rad MM, Luermans JGLM et al (2016) Identifying delayed left ventricular lateral wall activation in patients with non-specific intraventricular conduction delay using coronary venous electroanatomical mapping. Neth Heart\u00a0J 24:58\u201365. \n                    https:\/\/doi.org\/10.1007\/s12471-015-0777-3","journal-title":"Neth Heart J"},{"key":"4710_CR19","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/j.jacc.2017.02.042","volume":"69","author":"V Sundaram","year":"2017","unstructured":"Sundaram V, Sahadevan J, Waldo AL et al (2017) Implantable cardioverter-defibrillators with versus without resynchronization therapy in patients with a\u00a0QRS duration\u00a0\u3009180\u202fms. J\u00a0Am Coll Cardiol 69:2026\u20132036. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2017.02.042","journal-title":"J Am Coll Cardiol"},{"key":"4710_CR20","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/CIRCULATIONAHA.110.000646","volume":"123","author":"JP Singh","year":"2011","unstructured":"Singh JP, Klein HU, Huang DT et al (2011) Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation 123:1159\u20131166. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.000646","journal-title":"Circulation"},{"key":"4710_CR21","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/eurheartj\/ehs334","volume":"34","author":"V Kutyifa","year":"2013","unstructured":"Kutyifa V, Zareba W, McNitt S et al (2013) Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial. Eur Heart\u00a0J 34:184\u2013190. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehs334","journal-title":"Eur Heart J"},{"key":"4710_CR22","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.jacc.2011.12.030","volume":"59","author":"FZ Khan","year":"2012","unstructured":"Khan FZ, Virdee MS, Palmer CR et\u00a0al (2012) Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a\u00a0randomized, controlled trial. J\u00a0Am Coll Cardiol 59:1509\u20131518. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2011.12.030","journal-title":"J Am Coll Cardiol"},{"key":"4710_CR23","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1093\/eurheartj\/ehr329","volume":"32","author":"MR Gold","year":"2011","unstructured":"Gold MR, Birgersdotter-Green U, Singh JP et al (2011) The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy. Eur Heart\u00a0J 32:2516\u20132524. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehr329","journal-title":"Eur Heart J"},{"key":"4710_CR24","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.hrthm.2011.04.015","volume":"8","author":"DL Hayes","year":"2011","unstructured":"Hayes DL, Boehmer JP, Day JD et\u00a0al (2011) Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 8:1469\u20131475. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2011.04.015","journal-title":"Heart Rhythm"},{"key":"4710_CR25","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jacc.2011.10.891","volume":"59","author":"AN Ganesan","year":"2012","unstructured":"Ganesan AN, Brooks AG, Roberts-Thomson KC et al (2012) Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a\u00a0systematic review. J\u00a0Am Coll Cardiol 59:719\u2013726. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2011.10.891","journal-title":"J Am Coll Cardiol"},{"key":"4710_CR26","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D et\u00a0al (2016) 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893\u20132962. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehw210","journal-title":"Eur. Heart J."},{"key":"4710_CR27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1540-8159.2006.00354.x","volume":"29","author":"JW Schrickel","year":"2006","unstructured":"Schrickel JW, Schwab JO, Yang A et al (2006) \u201cTorsade de pointes\u201d in patients with structural heart disease and atrial fibrillation treated with amiodarone, beta-blockers, and digitalis. Pacing Clin Electrophysiol 29:363\u2013366. \n                    https:\/\/doi.org\/10.1111\/j.1540-8159.2006.00354.x","journal-title":"Pacing Clin Electrophysiol"},{"key":"4710_CR28","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","volume":"133","author":"L Biase Di","year":"2016","unstructured":"Di Biase L, Mohanty P, Mohanty S et\u00a0al (2016) Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation 133:1637\u20131644. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.019406","journal-title":"Circulation"},{"key":"4710_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche NF, Brachmann J, Andresen D et\u00a0al (2018) Catheter ablation for atrial fibrillation with heart failure. N\u00a0Engl J Med 378:417\u2013427. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1707855","journal-title":"N Engl J Med"},{"key":"4710_CR30","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1161\/CIRCEP.112.973776","volume":"5","author":"A Cheng","year":"2012","unstructured":"Cheng A, Landman SR, Stadler RW (2012) Reasons for loss of cardiac resynchronization therapy pacing: insights from 32 844 patients. Circ Arrhythm Electrophysiol 5:884\u2013888. \n                    https:\/\/doi.org\/10.1161\/CIRCEP.112.973776","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"4710_CR31","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.jacc.2012.06.035","volume":"60","author":"D Lakkireddy","year":"2012","unstructured":"Lakkireddy D, Di Biase L, Ryschon K et\u00a0al (2012) Radiofrequency ablation of premature ventricular ectopy improves the efficacy of cardiac resynchronization therapy in nonresponders. J\u00a0Am Coll Cardiol 60:1531\u20131539. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2012.06.035","journal-title":"J. Am. Coll. Cardiol."},{"key":"4710_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/CIRCULATIONAHA.113.006124","volume":"130","author":"J Steffel","year":"2014","unstructured":"Steffel J, Ruschitzka F (2014) Superresponse to cardiac resynchronization therapy. Circulation 130:87\u201390. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.006124","journal-title":"Circulation"},{"key":"4710_CR33","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jacc.2008.11.024","volume":"53","author":"W Mullens","year":"2009","unstructured":"Mullens W, Grimm RA, Verga T et\u00a0al (2009) Insights from a\u00a0cardiac resynchronization optimization clinic as part of a\u00a0heart failure disease management program. J\u00a0Am Coll Cardiol 53:765\u2013773. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2008.11.024","journal-title":"J Am Coll Cardiol"},{"key":"4710_CR34","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1016\/j.jacc.2012.01.065","volume":"59","author":"JC Hsu","year":"2012","unstructured":"Hsu JC, Solomon SD, Bourgoun M et al (2012) Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. J\u00a0Am Coll Cardiol 59:2366\u20132373. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2012.01.065","journal-title":"J Am Coll Cardiol"},{"key":"4710_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/europace\/eup038","volume":"11","author":"N Ant\u00f3nio","year":"2009","unstructured":"Ant\u00f3nio N, Teixeira R, Coelho L et al (2009) Identification of \u201csuper-responders\u201d to cardiac resynchronization therapy: the importance of symptom duration and left ventricular geometry. Europace 11:343\u2013349. \n                    https:\/\/doi.org\/10.1093\/europace\/eup038","journal-title":"Europace"},{"key":"4710_CR36","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1161\/CIRCULATIONAHA.112.001239","volume":"127","author":"B Thibault","year":"2013","unstructured":"Thibault B, Harel F, Ducharme A et al (2013) Cardiac resynchronization therapy in patients with heart failure and a\u00a0QRS complex \u3008120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial. Circulation 127:873\u2013881. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.001239","journal-title":"Circulation"},{"key":"4710_CR37","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1306687","volume":"369","author":"F Ruschitzka","year":"2013","unstructured":"Ruschitzka F, Abraham WT, Singh JP et al (2013) Cardiac-resynchronization therapy in heart failure with a\u00a0narrow QRS complex. N\u00a0Engl J Med 369:1395\u20131405. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1306687","journal-title":"N Engl J Med"},{"key":"4710_CR38","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.hrthm.2016.05.015","volume":"13","author":"F Zanon","year":"2016","unstructured":"Zanon F, Marcantoni L, Baracca E et\u00a0al (2016) Optimization of left ventricular pacing site plus multipoint pacing improves remodeling and clinical response to cardiac resynchronization therapy at 1 year. Heart Rhythm 13:1644\u20131651. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2016.05.015","journal-title":"Heart Rhythm"},{"key":"4710_CR39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/jce.12513","volume":"26","author":"C Pappone","year":"2015","unstructured":"Pappone C, Calovic \u017d, Vicedomini G et al (2015) Multipoint left ventricular pacing in a\u00a0single coronary sinus branch improves mid-term echocardiographic and clinical response to cardiac resynchronization therapy. J\u00a0Cardiovasc Electrophysiol 26:58\u201363. \n                    https:\/\/doi.org\/10.1111\/jce.12513","journal-title":"J Cardiovasc Electrophysiol"},{"key":"4710_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2017.06.022","author":"I Niazi","year":"2017","unstructured":"Niazi I, Baker J II, Corbisiero R et\u00a0al (2017) Safety and efficacy of multipoint pacing in cardiac resynchronization therapy. JACC Clin Electrophysiol:1\u20139. \n                    https:\/\/doi.org\/10.1016\/j.jacep.2017.06.022","journal-title":"JACC Clin Electrophysiol"},{"key":"4710_CR41","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.jacc.2007.11.074","volume":"51","author":"C Leclercq","year":"2008","unstructured":"Leclercq C, Gadler F, Kranig W et al (2008) A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure. J\u00a0Am Coll Cardiol 51:1455\u20131462. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2007.11.074","journal-title":"J Am Coll Cardiol"},{"key":"4710_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2017.12.028","author":"P Bordachar","year":"2017","unstructured":"Bordachar P, Gras D, Clementy N et\u00a0al (2017) Clinical impact of an additional left ventricular lead in cardiac resynchronization nonresponders: the V3 trial. Heart Rhythm. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2017.12.028","journal-title":"Heart Rhythm"},{"key":"4710_CR43","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.jacc.2017.02.059","volume":"69","author":"VY Reddy","year":"2017","unstructured":"Reddy VY, Miller MA, Neuzil P et al (2017) Cardiac resynchronization therapy with wireless left ventricular endocardial pacing: the\u00a0SELECT-LV study. J\u00a0Am Coll Cardiol 69:2119\u20132129. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2017.02.059","journal-title":"J Am Coll Cardiol"},{"key":"4710_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2018.02.032","author":"JHP Gamble","year":"2018","unstructured":"Gamble JHP, Herring N, Ginks MR et\u00a0al (2018) Endocardial left ventricular pacing across the interventricular septum for cardiac resynchronization therapy: clinical results of a\u00a0pilot study. Heart Rhythm. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2018.02.032","journal-title":"Heart Rhythm"},{"key":"4710_CR45","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1378\/chest.122.2.528","volume":"122","author":"HJ Shenkman","year":"2002","unstructured":"Shenkman HJ, Pampati V, Khandelwal AK et\u00a0al (2002) Congestive heart failure and QRS duration: establishing prognosis study. Chest 122:528\u2013534. \n                    https:\/\/doi.org\/10.1378\/chest.122.2.528","journal-title":"Chest"},{"key":"4710_CR46","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004381","author":"TC Randolph","year":"2017","unstructured":"Randolph TC, Broderick S, Shaw LK et\u00a0al (2017) Race and sex differences in QRS interval and associated outcome among patients with left ventricular systolic dysfunction. J\u00a0Am Heart Assoc. \n                    https:\/\/doi.org\/10.1161\/JAHA.116.004381","journal-title":"J Am Heart Assoc"},{"key":"4710_CR47","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jchf.2015.05.008","volume":"3","author":"NA Chatterjee","year":"2015","unstructured":"Chatterjee NA, Singh JP (2015) Novel interventional therapies to modulate the autonomic tone in heart failure. Jacc Heart Fail 3:786\u2013802. \n                    https:\/\/doi.org\/10.1016\/j.jchf.2015.05.008","journal-title":"Jacc Heart Fail"},{"key":"4710_CR48","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/ejhf.921","volume":"19","author":"M Bilsen van","year":"2017","unstructured":"van Bilsen M, Patel HC, Bauersachs J et\u00a0al (2017) The autonomic nervous system as a\u00a0therapeutic target in heart failure: a\u00a0scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 19:1361\u20131378. \n                    https:\/\/doi.org\/10.1002\/ejhf.921","journal-title":"Eur J Heart Fail"},{"key":"4710_CR49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jacc.2016.03.525","volume":"68","author":"MR Gold","year":"2016","unstructured":"Gold MR, Van Veldhuisen DJ, Hauptman PJ et al (2016) Vagus nerve stimulation for the treatment of heart failure: the INOVATE-HF trial. J\u00a0Am Coll Cardiol 68:149\u2013158. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2016.03.525","journal-title":"J Am Coll Cardiol"},{"key":"4710_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jchf.2015.10.006","volume":"4","author":"DP Zipes","year":"2016","unstructured":"Zipes DP, Neuzil P, Theres H et al (2016) Determining the feasibility of spinal cord neuromodulation for the treatment of chronic systolic heart failure: the DEFEAT-HF study. Jacc Heart Fail 4:129\u2013136. \n                    https:\/\/doi.org\/10.1016\/j.jchf.2015.10.006","journal-title":"Jacc Heart Fail"},{"key":"4710_CR51","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jjcc.2016.06.015","volume":"69","author":"S R\u00f6ger","year":"2017","unstructured":"R\u00f6ger S, Said S, Kloppe A et\u00a0al (2017) Cardiac contractility modulation in heart failure patients: randomized comparison of signal delivery through one vs. two ventricular leads. J\u00a0Cardiol 69:326\u2013332. \n                    https:\/\/doi.org\/10.1016\/j.jjcc.2016.06.015","journal-title":"J Cardiol"},{"key":"4710_CR52","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1016\/j.hrthm.2015.06.022","volume":"12","author":"J Kuschyk","year":"2015","unstructured":"Kuschyk J, Stach K, T\u00fcl\u00fcmen E et al (2015) Subcutaneous implantable cardioverter-defibrillator: first single-center experience with other cardiac implantable electronic devices. Heart Rhythm 12:2230\u20132238. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2015.06.022","journal-title":"Heart Rhythm"},{"key":"4710_CR53","doi-asserted-by":"publisher","first-page":"114","DOI":"10.5603\/CJ.a2015.0073","volume":"23","author":"A Kloppe","year":"2016","unstructured":"Kloppe A, Mijic D, Schiedat F et\u00a0al (2016) A randomized comparison of 5 versus 12\u202fh per day of cardiac contractility modulation treatment for heart failure patients: a preliminary report. Cardiol\u00a0J 23:114\u2013119. \n                    https:\/\/doi.org\/10.5603\/CJ.a2015.0073","journal-title":"Cardiol J"},{"key":"4710_CR54","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cardfail.2006.11.004","volume":"13","author":"C Butter","year":"2007","unstructured":"Butter C, Wellnhofer E, Schlegl M et\u00a0al (2007) Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption. J\u00a0Card Fail 13:137\u2013142. \n                    https:\/\/doi.org\/10.1016\/j.cardfail.2006.11.004","journal-title":"J Card Fail"},{"key":"4710_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1023\/A:1009851107189","volume":"6","author":"D Burkhoff","year":"2001","unstructured":"Burkhoff D, Shemer I, Felzen B et\u00a0al (2001) Electric currents applied during the refractory period can modulate cardiac contractility in vitro and in vivo. Heart Fail Rev 6:27\u201334","journal-title":"Heart Fail Rev"},{"key":"4710_CR56","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1054\/jcaf.2003.8","volume":"9","author":"H Morita","year":"2003","unstructured":"Morita H, Suzuki G, Haddad W et\u00a0al (2003) Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure. J\u00a0Card Fail 9:69\u201375. \n                    https:\/\/doi.org\/10.1054\/jcaf.2003.8","journal-title":"J Card Fail"},{"key":"4710_CR57","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ejheart.2003.11.001","volume":"6","author":"H Morita","year":"2004","unstructured":"Morita H, Suzuki G, Haddad W et al (2004) Long-term effects of non-excitatory cardiac contractility modulation electric signals on the progression of heart failure in dogs. Eur J Heart Fail 6:145\u2013150. \n                    https:\/\/doi.org\/10.1016\/j.ejheart.2003.11.001","journal-title":"Eur J Heart Fail"},{"key":"4710_CR58","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrcardio.2013.114","volume":"10","author":"AR Lyon","year":"2013","unstructured":"Lyon AR, Samara MA, Feldman DS (2013) Cardiac contractility modulation therapy in advanced systolic heart failure. Nat Rev Cardiol 10:584\u2013598. \n                    https:\/\/doi.org\/10.1038\/nrcardio.2013.114","journal-title":"Nat Rev Cardiol"},{"key":"4710_CR59","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.jacc.2008.01.036","volume":"51","author":"C Butter","year":"2008","unstructured":"Butter C, Rastogi S, Minden H\u2011H et al (2008) Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J\u00a0Am Coll Cardiol 51:1784\u20131789. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2008.01.036","journal-title":"J Am Coll Cardiol"},{"key":"4710_CR60","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/S0002-9149(02)02868-0","volume":"90","author":"C Pappone","year":"2002","unstructured":"Pappone C, Rosanio S, Burkhoff D et\u00a0al (2002) Cardiac contractility modulation by electric currents applied during the refractory period in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 90:1307\u20131313","journal-title":"Am J Cardiol"},{"key":"4710_CR61","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ehj.2004.02.027","volume":"25","author":"G Stix","year":"2004","unstructured":"Stix G, Borggrefe M, Wolpert C et\u00a0al (2004) Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure. Eur Heart\u00a0J 25:650\u2013655. \n                    https:\/\/doi.org\/10.1016\/j.ehj.2004.02.027","journal-title":"Eur Heart J"},{"key":"4710_CR62","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/eurheartj\/ehn020","volume":"29","author":"MM Borggrefe","year":"2008","unstructured":"Borggrefe MM, Lawo T, Butter C et al (2008) Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart\u00a0J 29:1019\u20131028. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehn020","journal-title":"Eur Heart J"},{"issue":"2","key":"4710_CR63","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ahj.2010.10.025","volume":"161","author":"A Kadish","year":"2011","unstructured":"Kadish A, Nademanee K, Volosin K et\u00a0al (2011) A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart\u00a0J 161(2):329\u2013337.e1. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2010.10.025","journal-title":"Am Heart J"},{"key":"4710_CR64","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.cardfail.2011.05.006","volume":"17","author":"WT Abraham","year":"2011","unstructured":"Abraham WT, Nademanee K, Volosin K et\u00a0al (2011) Subgroup analysis of a\u00a0randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. J\u00a0Card Fail 17:710\u2013717. \n                    https:\/\/doi.org\/10.1016\/j.cardfail.2011.05.006","journal-title":"J Card Fail"},{"key":"4710_CR65","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1093\/europace\/eur153","volume":"13","author":"T Schau","year":"2011","unstructured":"Schau T, Seifert M, Meyh\u00f6fer J et al (2011) Long-term outcome of cardiac contractility modulation in patients with severe congestive heart failure. Europace 13:1436\u20131444. \n                    https:\/\/doi.org\/10.1093\/europace\/eur153","journal-title":"Europace"},{"key":"4710_CR66","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ijcard.2014.12.178","volume":"183","author":"J Kuschyk","year":"2015","unstructured":"Kuschyk J, Roeger S, Schneider R et al (2015) Efficacy and survival in patients with cardiac contractility modulation: long-term single center experience in 81 patients. Int J Cardiol 183:76\u201381. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2014.12.178","journal-title":"Int J Cardiol"},{"key":"4710_CR67","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ijcard.2016.02.001","volume":"209","author":"A Kloppe","year":"2016","unstructured":"Kloppe A, Lawo T, Mijic D et al (2016) Long-term survival with cardiac contractility modulation in patients with NYHA II or III symptoms and normal QRS duration. Int J Cardiol 209:291\u2013295. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2016.02.001","journal-title":"Int J Cardiol"},{"key":"4710_CR68","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijcard.2016.01.071","volume":"206","author":"M Liu","year":"2016","unstructured":"Liu M, Fang F, Luo XX et al (2016) Improvement of long-term survival by cardiac contractility modulation in heart failure patients: a case-control study. Int J Cardiol 206:122\u2013126. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2016.01.071","journal-title":"Int J Cardiol"},{"key":"4710_CR69","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S1053-2498(02)00431-X","volume":"21","author":"F Grigioni","year":"2002","unstructured":"Grigioni F, Carinci V, Boriani G et\u00a0al (2002) Accelerated QRS widening as an independent predictor of cardiac death or of the need for heart transplantation in patients with congestive heart failure. J\u00a0Heart Lung Transplant 21:899\u2013902","journal-title":"J. Heart Lung Transplant."},{"key":"4710_CR70","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.jelectrocard.2014.08.011","volume":"47","author":"S R\u00f6ger","year":"2014","unstructured":"R\u00f6ger S, Michels J, Heggemann F et\u00a0al (2014) Long term impact of cardiac contractility modulation on QRS duration. J\u00a0Electrocardiol 47:936\u2013940. \n                    https:\/\/doi.org\/10.1016\/j.jelectrocard.2014.08.011","journal-title":"J Electrocardiol"},{"key":"4710_CR71","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/europace\/eun257","volume":"10","author":"H Nagele","year":"2008","unstructured":"Nagele H, Behrens S, Eisermann C (2008) Cardiac contractility modulation in non-responders to cardiac resynchronization therapy. Europace 10:1375\u20131380. \n                    https:\/\/doi.org\/10.1093\/europace\/eun257","journal-title":"Europace"},{"key":"4710_CR72","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jacc.2011.06.008","volume":"58","author":"JD Bisognano","year":"2011","unstructured":"Bisognano JD, Bakris G, Nadim MK et al (2011) Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J\u00a0Am Coll Cardiol 58:765\u2013773. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2011.06.008","journal-title":"J Am Coll Cardiol"},{"key":"4710_CR73","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1161\/CIRCRESAHA.114.302589","volume":"114","author":"VG Florea","year":"2014","unstructured":"Florea VG, Cohn JN (2014) The autonomic nervous system and heart failure. Circ Res 114:1815\u20131826. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.302589","journal-title":"Circ Res"},{"key":"4710_CR74","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/HYPERTENSIONAHA.107.095216","volume":"50","author":"IH Zucker","year":"2007","unstructured":"Zucker IH, Hackley JF, Cornish KG et al (2007) Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure. Hypertension 50:904\u2013910. \n                    https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.107.095216","journal-title":"Hypertension"},{"key":"4710_CR75","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1161\/CIRCHEARTFAILURE.110.955013","volume":"4","author":"HN Sabbah","year":"2011","unstructured":"Sabbah HN, Gupta RC, Imai M et\u00a0al (2011) Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure. Circ Heart Fail 4:65\u201370. \n                    https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.110.955013","journal-title":"Circ Heart Fail"},{"key":"4710_CR76","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/ejhf.138","volume":"16","author":"E Gronda","year":"2014","unstructured":"Gronda E, Seravalle G, Brambilla G et al (2014) Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a\u00a0proof-of-concept study. Eur J Heart Fail 16:977\u2013983. \n                    https:\/\/doi.org\/10.1002\/ejhf.138","journal-title":"Eur J Heart Fail"},{"key":"4710_CR77","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jchf.2015.02.006","volume":"3","author":"WT Abraham","year":"2015","unstructured":"Abraham WT, Zile MR, Weaver FA et\u00a0al (2015) Baroreflex activation therapy for the treatment of heart failure with a\u00a0reduced ejection fraction. Jacc Heart Fail 3:487\u2013496. \n                    https:\/\/doi.org\/10.1016\/j.jchf.2015.02.006","journal-title":"Jacc Heart Fail"},{"key":"4710_CR78","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/ejhf.299","volume":"17","author":"MR Zile","year":"2015","unstructured":"Zile MR, Abraham WT, Weaver FA et\u00a0al (2015) Baroreflex activation therapy for the treatment of heart failure with a\u00a0reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy. Eur J Heart Fail 17:1066\u20131074. \n                    https:\/\/doi.org\/10.1002\/ejhf.299","journal-title":"Eur J Heart Fail"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-018-4710-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-018-4710-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-018-4710-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T19:26:08Z","timestamp":1557343568000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-018-4710-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,9]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["4710"],"URL":"https:\/\/doi.org\/10.1007\/s00059-018-4710-6","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"type":"print","value":"0340-9937"},{"type":"electronic","value":"1615-6692"}],"subject":[],"published":{"date-parts":[[2018,5,9]]},"assertion":[{"value":"9 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"D.\u00a0Duncker received lecture honoraria, travel support, and a fellowship grant from Biotronik, Boston Scientific, Medtronic, Sorin\/LivaNova, St. Jude Medical\/Abbott, and Zoll. C.\u00a0Veltmann received lecture honoraria and travel support from Biotronik, CVRX, Boston Scientific, Medtronic, St. Jude Medical\/Abbott, and Zoll.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}